Research verifies : Morbidity and hormone of breast cancer have something to do with the treatment

Research verifies : Morbidity and hormone of breast cancer have something to do with the treatment

A latest research in Canada verifies, the morbidity of involutional woman's breast cancer drops and reduces, uses hormone to have something to do with the treatment greatly.
It is that one kind reduces woman's involutional symptom, treatment slowing aging slowly through supplementing estrogen and progestogen that hormone substitutes the treatment. In 2002, a large-scale clinical trial of U.S.A. revealed, hormone will increase the risks of breast cancer, heart disease and apoplexy in place of the treatment, its fraud is greater than the profit. Later, a lot of Canadian women stopped using hormone to substitute the treatment.
The researchers of the Canadian cancer association are in 23 U.S.A. which Japan publishes>On if you can't deliver, if you can't study, say,carry on investigation of they about 1200 age between 50 and 69 years old Canadian woman, found finally, from 2002 to 2004, suffered from the case of breast cancer to drop in these women by about 10%.
The author of the research report thinks, reduce and use hormone to substitute the treatment and years old to 69 years old Canadian women's breast cancer morbidity 50 and exist and is concerned with while dropping. This discovery has verified the relevant research of other countries such as U.S.A. too, namely the morbidity of breast cancer drops as women stop using hormone in place of the treatment. However, researchers have not totally confirmed hormone in place of how the treatment influenced morbidity of breast cancer yet.
|